Searchable abstracts of presentations at key conferences in endocrinology

ea0086p165 | Adrenal and Cardiovascular | SFEBES2022

Oral itraconazole augments iatrogenic Cushing’s syndrome and adrenal insufficiency after medication withdrawal

Maarouf Amro , Joseph Sonia , Juszczak Agata

A 37-year-old woman was referred to the endocrine team for the assessment of her adrenal axis, as she had been taking high dose prednisolone (20-40 mg) for several years for the management of her brittle asthma. Drug history included inhaled Symbicort 200/6 (SMART regime), tiotropium and montelukast. Her respiratory symptoms improved with the introduction of theophylline, thus enabling her prednisolone to be switched to oral hydrocortisone, with appropriate ’sick- day&#14...

ea0094p190 | Bone and Calcium | SFEBES2023

Parenteral bisphosphonate therapy is effective and safe when given prior to parathyroid surgery in severe primary hyperparathyroidism

Maarouf Amro , Winfield Jessica , Hazlehurst Jonathan , Joseph Sonia , Shepherd Lisa , Rahim Asad , Juszczak Agata

Background: Primary hyperparathyroidism may severely manifest with an adjusted calcium >3.5mmol/l and increased risk of prolonged postoperative hypocalcaemia. Formal consensus on preoperative optimisation appears lacking, especially around the utility of parenteral bisphosphonate treatment. Bisphosphonate therapy has been demonstrated to cause prolonged hypocalcaemia when given to patients with a history of parathyroidectomy....